2022 Q4 Form 10-Q Financial Statement

#000095017022021883 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $184.5M $167.7M $108.3M
YoY Change -5.42% 54.92% 707.14%
Cost Of Revenue $77.49M $61.33M $60.09M
YoY Change 4.7% 2.07% 1391.07%
Gross Profit $107.0M $106.4M $48.18M
YoY Change -11.61% 120.84% 413.65%
Gross Profit Margin 58.0% 63.43% 44.5%
Selling, General & Admin $30.38M $32.04M $26.93M
YoY Change 5.5% 19.0% 25.02%
% of Gross Profit 28.39% 30.11% 55.89%
Research & Development $12.85M $12.96M $6.186M
YoY Change 15.62% 109.54% -27.4%
% of Gross Profit 12.01% 12.18% 12.84%
Depreciation & Amortization $837.0K $890.0K $1.078M
YoY Change -17.62% -17.44% -2.88%
% of Gross Profit 0.78% 0.84% 2.24%
Operating Expenses $43.24M $45.00M $33.11M
YoY Change 8.32% 35.91% 10.16%
Operating Profit $63.77M $61.40M $16.07M
YoY Change -21.41% 282.11% -216.22%
Interest Expense $2.640M $1.685M $1.676M
YoY Change -84.96% 0.54% -65.04%
% of Operating Profit 4.14% 2.74% 10.43%
Other Income/Expense, Net $2.199M -$208.0K $238.0K
YoY Change -5.26% -187.39% -156.67%
Pretax Income $67.97M $64.09M -$28.43M
YoY Change -32.42% -325.44% -746.14%
Income Tax $241.0K $300.0K $0.00
% Of Pretax Income 0.35% 0.47%
Net Earnings $67.45M $63.81M -$28.43M
YoY Change -32.4% -324.44% -745.99%
Net Earnings / Revenue 36.56% 38.04% -26.26%
Basic Earnings Per Share $0.50 -$0.24
Diluted Earnings Per Share $0.44 $0.43 -$0.24
COMMON SHARES
Basic Shares Outstanding 127.6M 126.5M 116.9M
Diluted Shares Outstanding 151.5M 116.9M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $624.4M $586.5M $414.2M
YoY Change 14.37% 41.61% 133.72%
Cash & Equivalents $202.0M $198.6M $246.4M
Short-Term Investments $422.4M $387.9M $167.8M
Other Short-Term Assets $85.63M $112.7M $170.9M
YoY Change -63.32% -34.02% 808.81%
Inventory $59.45M $102.6M $67.30M
Prepaid Expenses
Receivables $145.1M $129.8M $200.4M
Other Receivables $2.385M $1.346M $0.00
Total Short-Term Assets $917.0M $932.9M $852.7M
YoY Change -5.71% 9.41% 194.02%
LONG-TERM ASSETS
Property, Plant & Equipment $37.60M $35.35M $34.25M
YoY Change 7.36% 3.21% -40.64%
Goodwill $2.006M $1.835M $2.171M
YoY Change -5.6% -15.48%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.311M $3.337M $3.623M
YoY Change -2.56% -7.89% 3.51%
Total Long-Term Assets $68.87M $66.39M $67.04M
YoY Change 3.21% -0.97% 5.74%
TOTAL ASSETS
Total Short-Term Assets $917.0M $932.9M $852.7M
Total Long-Term Assets $68.87M $66.39M $67.04M
Total Assets $985.9M $999.3M $919.7M
YoY Change -5.14% 8.66% 160.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.211M $3.050M $3.596M
YoY Change 23.5% -15.18% -32.15%
Accrued Expenses $30.72M $38.21M $87.91M
YoY Change -38.31% -56.54% 277.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $150.1M $244.1M $528.9M
YoY Change -73.03% -53.85% 694.2%
LONG-TERM LIABILITIES
Long-Term Debt $221.6M $221.3M $220.2M
YoY Change 0.49% 22.55%
Other Long-Term Liabilities $384.0K $251.0K $79.00K
YoY Change -93.22% 217.72% -99.79%
Total Long-Term Liabilities $384.0K $251.0K $79.00K
YoY Change -93.22% 217.72% -99.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $150.1M $244.1M $528.9M
Total Long-Term Liabilities $384.0K $251.0K $79.00K
Total Liabilities $404.8M $498.8M $852.1M
YoY Change -50.44% -41.47% 199.94%
SHAREHOLDERS EQUITY
Retained Earnings -$924.2M -$991.9M -$1.317B
YoY Change -24.08% -24.69%
Common Stock $1.511B $1.502B $1.386B
YoY Change 4.76% 8.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $581.0M $500.6M $67.58M
YoY Change
Total Liabilities & Shareholders Equity $985.9M $999.3M $919.7M
YoY Change -5.14% 8.66% 160.25%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $67.45M $63.81M -$28.43M
YoY Change -32.4% -324.44% -745.99%
Depreciation, Depletion And Amortization $837.0K $890.0K $1.078M
YoY Change -17.62% -17.44% -2.88%
Cash From Operating Activities $34.95M $61.56M $66.21M
YoY Change -71.0% -7.02% -338.0%
INVESTING ACTIVITIES
Capital Expenditures $1.587M -$1.281M -$3.629M
YoY Change -152.27% -64.7% 1295.77%
Acquisitions
YoY Change
Other Investing Activities -$31.38M -$117.8M $49.30M
YoY Change -154.13% -338.87% -2854.25%
Cash From Investing Activities -$32.97M -$119.0M $45.67M
YoY Change -160.01% -360.66% -2327.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 153.0K 8.057M 5.322M
YoY Change -98.97% 51.39% 277.45%
NET CHANGE
Cash From Operating Activities 34.95M 61.56M 66.21M
Cash From Investing Activities -32.97M -119.0M 45.67M
Cash From Financing Activities 153.0K 8.057M 5.322M
Net Change In Cash 2.134M -49.43M 117.2M
YoY Change -98.88% -142.17% -511.82%
FREE CASH FLOW
Cash From Operating Activities $34.95M $61.56M $66.21M
Capital Expenditures $1.587M -$1.281M -$3.629M
Free Cash Flow $33.36M $62.84M $69.84M
YoY Change -72.99% -10.02% -353.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94608
dei City Area Code
CityAreaCode
510
us-gaap Inventory Write Down
InventoryWriteDown
0
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1000000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1000000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-698000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001029142
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34207
dei Entity Registrant Name
EntityRegistrantName
Dynavax Technologies Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0728374
dei Entity Address Address Line1
EntityAddressAddressLine1
2100 Powell Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 720
dei Entity Address City Or Town
EntityAddressCityOrTown
Emeryville
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Local Phone Number
LocalPhoneNumber
848-5100
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
DVAX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
127584879
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
198576000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
436189000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
387910000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
109761000
CY2022Q3 us-gaap Other Receivables
OtherReceivables
1346000
CY2021Q4 us-gaap Other Receivables
OtherReceivables
15600000
CY2022Q3 us-gaap Inventory Net
InventoryNet
102609000
CY2021Q4 us-gaap Inventory Net
InventoryNet
61335000
CY2022Q3 dvax Prepaid Manufacturing
PrepaidManufacturing
12727000
CY2021Q4 dvax Prepaid Manufacturing
PrepaidManufacturing
159655000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
100004000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
73764000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
932944000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
972520000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35352000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35020000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25680000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25964000
CY2022Q3 us-gaap Goodwill
Goodwill
1835000
CY2021Q4 us-gaap Goodwill
Goodwill
2125000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
189000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
219000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3337000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3398000
CY2022Q3 us-gaap Assets
Assets
999337000
CY2021Q4 us-gaap Assets
Assets
1039246000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3050000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2600000
CY2022Q3 dvax Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
4300000
CY2021Q4 dvax Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
4688000
CY2022Q3 dvax Coalition For Epidemic Preparedness Innovations Accruals
CoalitionForEpidemicPreparednessInnovationsAccruals
107738000
CY2021Q4 dvax Coalition For Epidemic Preparedness Innovations Accruals
CoalitionForEpidemicPreparednessInnovationsAccruals
128848000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38209000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49796000
CY2022Q3 dvax Warrant Liability Current
WarrantLiabilityCurrent
0
CY2021Q4 dvax Warrant Liability Current
WarrantLiabilityCurrent
18016000
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
87395000
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
349864000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3388000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2590000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
244080000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
556402000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4197000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5010000
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
221303000
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
220490000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33127000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34316000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
251000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5664000
CY2022Q3 us-gaap Liabilities
Liabilities
498761000
CY2021Q4 us-gaap Liabilities
Liabilities
816872000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
278000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
278000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
127581000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
127581000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
122945000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
122945000
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
127000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
123000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1501639000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1441868000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9262000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2266000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-991928000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1217351000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
500576000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
222374000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
999337000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1039246000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
167735000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108270000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
538191000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
244372000
CY2022Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
61334000
CY2021Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
60090000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
184665000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
99560000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12962000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6186000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33746000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21111000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32042000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26926000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
100393000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70932000
CY2022Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
CY2021Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1000000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1000000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1000000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
106338000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
92202000
us-gaap Costs And Expenses
CostsAndExpenses
317804000
us-gaap Costs And Expenses
CostsAndExpenses
190603000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
61397000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16068000
us-gaap Operating Income Loss
OperatingIncomeLoss
220387000
us-gaap Operating Income Loss
OperatingIncomeLoss
53769000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2562000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
39000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3588000
us-gaap Investment Income Interest
InvestmentIncomeInterest
134000
CY2022Q3 us-gaap Interest Expense
InterestExpense
1685000
CY2021Q3 us-gaap Interest Expense
InterestExpense
1676000
us-gaap Interest Expense
InterestExpense
5048000
us-gaap Interest Expense
InterestExpense
9497000
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
2026000
CY2021Q3 us-gaap Sublease Income
SubleaseIncome
2022000
us-gaap Sublease Income
SubleaseIncome
5660000
us-gaap Sublease Income
SubleaseIncome
5714000
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5232000
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
45121000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1801000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
68576000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-208000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
238000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-63000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
622000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
64092000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28430000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
226325000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23066000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
283000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
902000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
63809000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28430000
us-gaap Net Income Loss
NetIncomeLoss
225423000
us-gaap Net Income Loss
NetIncomeLoss
-23066000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.51
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127062000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116903000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125997000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114540000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151538000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116903000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
150433000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114540000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
63809000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28430000
us-gaap Net Income Loss
NetIncomeLoss
225423000
us-gaap Net Income Loss
NetIncomeLoss
-23066000
CY2022Q3 dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
-395000
CY2021Q3 dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
-18000
dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
-2296000
dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
11000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2307000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-797000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4700000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1812000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2702000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-815000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6996000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1801000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
61107000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29245000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
218427000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24867000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
422799000
CY2022Q3 dvax Issuance Of Common Stock Upon Exercise Of Stock Options And Or Release Of Restricted Stock Awards Net Amount
IssuanceOfCommonStockUponExerciseOfStockOptionsAndOrReleaseOfRestrictedStockAwardsNetAmount
7337000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
720000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8613000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2702000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
63809000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
500576000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
222374000
dvax Issuance Of Common Stock Upon Exercise Of Warrants
IssuanceOfCommonStockUponExerciseOfWarrants
24670000
dvax Issuance Of Common Stock Upon Exercise Of Stock Options And Or Release Of Restricted Stock Awards Net Amount
IssuanceOfCommonStockUponExerciseOfStockOptionsAndOrReleaseOfRestrictedStockAwardsNetAmount
9487000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1430000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24188000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6996000
us-gaap Net Income Loss
NetIncomeLoss
225423000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
500576000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
83380000
CY2021Q3 dvax Issuance Of Common Stock Upon Exercise Of Stock Options And Or Release Of Restricted Stock Awards Net Amount
IssuanceOfCommonStockUponExerciseOfStockOptionsAndOrReleaseOfRestrictedStockAwardsNetAmount
3982000
CY2021Q3 dvax Issuance Of Common Stock Upon Exercise Of Warrants
IssuanceOfCommonStockUponExerciseOfWarrants
3625000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
458000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5376000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-815000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28430000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
67576000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
58693000
dvax Issuance Of Common Stock Upon Exercise Of Stock Options And Or Release Of Restricted Stock Awards Net Amount
IssuanceOfCommonStockUponExerciseOfStockOptionsAndOrReleaseOfRestrictedStockAwardsNetAmount
5317000
dvax Issuance Of Common Stock Upon Exercise Of Warrants
IssuanceOfCommonStockUponExerciseOfWarrants
11553000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
841000
dvax Issuance Of Common Stock Net Of Issuance Costs In Conjunction With An Underwritten Public Offering And An At Market Sales Agreement
IssuanceOfCommonStockNetOfIssuanceCostsInConjunctionWithAnUnderwrittenPublicOfferingAndAnAtMarketSalesAgreement
28156000
dvax Issuance Of Capped Call Options See Note10
IssuanceOfCappedCallOptionsSeeNote10
-27240000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15123000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1801000
us-gaap Net Income Loss
NetIncomeLoss
-23066000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
67576000
us-gaap Net Income Loss
NetIncomeLoss
225423000
us-gaap Net Income Loss
NetIncomeLoss
-23066000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2975000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3280000
dvax Amortization Of Right Of Use Assets And Loss On Disposal Of Property And Equipment
AmortizationOfRightOfUseAssetsAndLossOnDisposalOfPropertyAndEquipment
2244000
dvax Amortization Of Right Of Use Assets And Loss On Disposal Of Property And Equipment
AmortizationOfRightOfUseAssetsAndLossOnDisposalOfPropertyAndEquipment
2013000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1969000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-442000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5232000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1801000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
68576000
us-gaap Share Based Compensation
ShareBasedCompensation
24188000
us-gaap Share Based Compensation
ShareBasedCompensation
15123000
dvax Non Cash Interest Expense
NonCashInterestExpense
2222000
dvax Non Cash Interest Expense
NonCashInterestExpense
2546000
us-gaap Inventory Write Down
InventoryWriteDown
14485000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
177701000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
55759000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3608000
dvax Increase Decrease In Prepaid Manufacturing
IncreaseDecreaseInPrepaidManufacturing
-146928000
dvax Increase Decrease In Prepaid Manufacturing
IncreaseDecreaseInPrepaidManufacturing
80340000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
26240000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
51887000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-61000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
50000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
301000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-545000
dvax Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
2366000
dvax Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
2416000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-262469000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
320376000
dvax Long Term Deferred Revenue
LongTermDeferredRevenue
0
dvax Long Term Deferred Revenue
LongTermDeferredRevenue
67969000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-19043000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
70087000
dvax Increase Decrease In Cepi Accrual
IncreaseDecreaseInCepiAccrual
-21110000
dvax Increase Decrease In Cepi Accrual
IncreaseDecreaseInCepiAccrual
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27768000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
215031000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
514676000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
164927000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
236200000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
129655000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5552000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6441000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1000000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-283028000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40713000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28156000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
219822000
dvax Payments For Purchase Of Capped Call Options
PaymentsForPurchaseOfCappedCallOptions
0
dvax Payments For Purchase Of Capped Call Options
PaymentsForPurchaseOfCappedCallOptions
27240000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
190194000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
8455000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
4258000
dvax Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
9487000
dvax Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
5317000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1430000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
841000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19372000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40960000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1755000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1013000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-237643000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
214265000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
436408000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32310000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
198765000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246575000
us-gaap Income Taxes Paid
IncomeTaxesPaid
788000
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Interest Paid Net
InterestPaidNet
2819000
us-gaap Interest Paid Net
InterestPaidNet
6965000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
973000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1561000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2475000
dvax Remeasurement Of Operating Lease Right Of Use Assets For Lease Modification
RemeasurementOfOperatingLeaseRightOfUseAssetsForLeaseModification
0
dvax Remeasurement Of Operating Lease Right Of Use Assets For Lease Modification
RemeasurementOfOperatingLeaseRightOfUseAssetsForLeaseModification
2468000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that may affect the amounts reported in the condensed consolidated financial statements and accompanying notes, including amounts of revenues and expenses during the reported periods. Management’s estimates are based on historical information available as of the date of the condensed consolidated financial statements and various other assumptions we believe are reasonable under the circumstances. On an ongoing basis, we evaluate our estimates, judgments and methodologies. Significant estimates and assumptions in the condensed consolidated financial statements include those related to revenue recognition; accounts receivable; useful lives of long-lived assets, impairment of long-lived assets, including goodwill; valuation procedures for right-of-use assets and operating lease liabilities; valuation of inventory; fair value of warrants; balance sheet classification of Convertible Notes; income taxes, including the valuation allowance for deferred tax assets; research and development expenses; contingencies and share-based compensation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ materially from these estimates under different assumptions or conditions and could be further impacted by the COVID-19 pandemic. Changes in estimates are reflected in reported results in the period in which they become known.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2022Q3 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
285400000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
36893000
CY2022Q3 dvax Lessor Sublease Rentals Payments To Be Received Remainder Of Fiscal Year
LessorSubleaseRentalsPaymentsToBeReceivedRemainderOfFiscalYear
1364000
dvax Inventory Write Offs Recognized
InventoryWriteOffsRecognized
14500000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
18016000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-1801000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
16215000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
198576000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
436189000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
246351000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32073000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
189000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
219000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
224000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
237000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
198765000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
436408000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246575000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32310000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
375208000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
372999000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
14998000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
14911000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
390206000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
387910000
CY2022Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0
CY2021Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
36509000
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
29170000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
26637000
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
20902000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14748000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
52537000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
19950000
CY2022Q3 us-gaap Inventory Net
InventoryNet
102609000
CY2021Q4 us-gaap Inventory Net
InventoryNet
61335000
dvax Provision For Write Down Of Inventory
ProvisionForWriteDownOfInventory
14500000
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1377000
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1535000
us-gaap Operating Lease Expense
OperatingLeaseExpense
4851000
us-gaap Operating Lease Expense
OperatingLeaseExpense
4665000
us-gaap Operating Lease Payments
OperatingLeasePayments
5100000
us-gaap Operating Lease Payments
OperatingLeasePayments
5200000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3382000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2577000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33127000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34316000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1659000
CY2022Q3 dvax Lessor Sublease Rentals Payments To Be Received Due Year Two
LessorSubleaseRentalsPaymentsToBeReceivedDueYearTwo
5518000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6749000
CY2022Q3 dvax Lessor Sublease Rentals Payments To Be Received Due Year Three
LessorSubleaseRentalsPaymentsToBeReceivedDueYearThree
5684000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6879000
CY2022Q3 dvax Lessor Sublease Rentals Payments To Be Received Due Year Four
LessorSubleaseRentalsPaymentsToBeReceivedDueYearFour
5854000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6266000
CY2022Q3 dvax Lessor Sublease Rentals Payments To Be Received Due Year Five
LessorSubleaseRentalsPaymentsToBeReceivedDueYearFive
6030000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5824000
CY2022Q3 dvax Lessor Sublease Rentals Payments To Be Received Due Thereafter
LessorSubleaseRentalsPaymentsToBeReceivedDueThereafter
27712000
CY2022Q3 dvax Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
26975000
CY2022Q3 dvax Lessor Sublease Rentals Payments To Be Received
LessorSubleaseRentalsPaymentsToBeReceived
52162000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
54352000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
17843000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
36509000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
63809000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y10M24D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M6D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.101
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.101
CY2022Q3 us-gaap Purchase Obligation
PurchaseObligation
61000000.0
CY2022Q3 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
285400000
CY2022Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1409000
CY2021Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1409000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4228000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2145000
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
273000
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
265000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
812000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
402000
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1682000
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1674000
us-gaap Interest Expense Debt
InterestExpenseDebt
5040000
us-gaap Interest Expense Debt
InterestExpenseDebt
2547000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
167735000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108270000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
538191000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
244372000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28430000
us-gaap Net Income Loss
NetIncomeLoss
225423000
us-gaap Net Income Loss
NetIncomeLoss
-23066000
CY2022Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
CY2021Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-291000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
63809000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28430000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
225132000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23066000
CY2022Q3 dvax Addition Of Undistributed Earnings Allocated To Participating Securities
AdditionOfUndistributedEarningsAllocatedToParticipatingSecurities
0
CY2021Q3 dvax Addition Of Undistributed Earnings Allocated To Participating Securities
AdditionOfUndistributedEarningsAllocatedToParticipatingSecurities
0
dvax Addition Of Undistributed Earnings Allocated To Participating Securities
AdditionOfUndistributedEarningsAllocatedToParticipatingSecurities
291000
dvax Addition Of Undistributed Earnings Allocated To Participating Securities
AdditionOfUndistributedEarningsAllocatedToParticipatingSecurities
0
CY2022Q3 dvax Fair Value Adjustments Of Warrants
FairValueAdjustmentsOfWarrants
0
CY2021Q3 dvax Fair Value Adjustments Of Warrants
FairValueAdjustmentsOfWarrants
0
dvax Fair Value Adjustments Of Warrants
FairValueAdjustmentsOfWarrants
-1801000
dvax Fair Value Adjustments Of Warrants
FairValueAdjustmentsOfWarrants
0
CY2022Q3 us-gaap Interest Expense Medium Term Notes
InterestExpenseMediumTermNotes
1262000
CY2021Q3 us-gaap Interest Expense Medium Term Notes
InterestExpenseMediumTermNotes
0
us-gaap Interest Expense Medium Term Notes
InterestExpenseMediumTermNotes
3780000
us-gaap Interest Expense Medium Term Notes
InterestExpenseMediumTermNotes
0
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
65071000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-28430000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
227402000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-23066000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127062000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116903000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125997000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114540000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2933000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2784000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2022Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2021Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
109000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2022Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
21543000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
21543000
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151538000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116903000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
150433000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114540000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5214000
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32362000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7417000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32712000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
127580921
CY2019Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
18525000
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 dvax Number Of Common Stock Warrant Exercised
NumberOfCommonStockWarrantExercised
1882600
CY2022Q1 dvax Cash Settlement Of Warrants
CashSettlementOfWarrants
8500000
CY2022Q2 dvax Increase In Number Of Employee Stock Purchase Plan Shares Authorized For Issuance
IncreaseInNumberOfEmployeeStockPurchasePlanSharesAuthorizedForIssuance
15000000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10399000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.55
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y1M28D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42756000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2053000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.54
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1171000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.10
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9348000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15323000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
9081000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
10.70
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y9M21D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
15241000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5056000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.10
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y11M12D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
12300000
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
8613000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
5376000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
24188000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
15123000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.004

Files In Submission

Name View Source Status
0000950170-22-021883-index-headers.html Edgar Link pending
0000950170-22-021883-index.html Edgar Link pending
0000950170-22-021883.txt Edgar Link pending
0000950170-22-021883-xbrl.zip Edgar Link pending
dvax-20220930.htm Edgar Link pending
dvax-20220930.xsd Edgar Link pending
dvax-ex10_1.htm Edgar Link pending
dvax-ex10_2.htm Edgar Link pending
dvax-ex10_3.htm Edgar Link pending
dvax-ex10_4.htm Edgar Link pending
dvax-ex31_1.htm Edgar Link pending
dvax-ex31_2.htm Edgar Link pending
dvax-ex32_1.htm Edgar Link pending
dvax-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
dvax-20220930_cal.xml Edgar Link unprocessable
dvax-20220930_def.xml Edgar Link unprocessable
dvax-20220930_pre.xml Edgar Link unprocessable
dvax-20220930_lab.xml Edgar Link unprocessable
dvax-20220930_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending